Skip to main content
. 2016 Mar 7;82(6):1818–1827. doi: 10.1128/AEM.02929-15

TABLE 4.

Characteristics of blaCTX-M-harboring E. coli isolates repeatedly recovered from 13 long-term carriers and blaCTX-M-harboring E. coli isolates simultaneously recovered from 2 participants

graphic file with name zam9991170020003.jpg

a

The data in the first three columns represent the personal identification number, gender (F, female; M, male), and age (in years), respectively.

b

-, not transferred; ND, the replicon type was not determined by PBRT.

c

•, detection of blaCTX-M-harboring E. coli; ×, no detection of blaCTX-M-harboring E. coli, even though fecal screening was performed; △, prescription of antimicrobial treatment; ○, overseas travel.

d

Isolates detected for a long period.

e

CIP, ciprofloxacin; LVX, levofloxacin; CTX, cefotaxime; PIP, piperacillin; MIN, minocycline; AZL, aztreonam; CAZ, ceftazidime; GEN, gentamicin; CHL, chloramphenicol.